Try a new search

Format these results:

Searched for:

person:ais1

Total Results:

177


Comparison of the effects of phospholamban and jasmone on the calcium pump of cardiac sarcoplasmic reticulum. Evidence for modulation by phospholamban of both Ca2+ affinity and Vmax (Ca) of calcium transport

Antipenko, A Y; Spielman, A I; Kirchberger, M A
Regulation of the calcium pump of the cardiac sarcoplasmic reticulum by phosphorylation/dephosphorylation of phospholamban is central to the inotropic and lusitropic effects of beta-adrenergic agonists on the heart. In order to study the mechanism of this regulation, we first obtained purified ruthenium red-insensitive microsomes enriched in sarcoplasmic reticulum membranes. The kinetics of microsomal Ca2+ uptake after phospholamban phosphorylation or trypsin treatment, which cleaves the inhibitory cytoplasmic domain of phospholamban, were then compared with those in the presence of jasmone, whose effects on the kinetics of fast skeletal muscle Ca2+-ATPase are largely known. All three treatments increased Vmax (Ca) at 25 degrees C and millimolar ATP; phosphorylation and trypsin decreased the Km (Ca), while jasmone increased it. Trypsin and jasmone increased the rate of E2P decomposition 1.8- and 3. 0-fold, respectively. The effects of phospholamban phosphorylation and jasmone on the Ca2+-ATPase activity paralleled their effects on Ca2+ uptake. Our data demonstrate that phospholamban regulates E2P decomposition in addition to the known increase in the rate of a conformational change in the Ca2+-ATPase upon binding the first of two Ca2+. These steps in the catalytic cycle of the Ca2+-ATPase may contribute to or account for phospholamban's effects on both Vmax (Ca) and Km (Ca), whose relative magnitude may vary under different experimental and, presumably, physiological conditions
PMID: 9006928
ISSN: 0021-9258
CID: 153036

Further characterization of salivary adhesion promoting protein [Meeting Abstract]

Akintoye, SO; Dasso, M; Ganeshkumar, N; Hay, DI; Bivona, P; Spielman, AI
ISI:A1997WB68001647
ISSN: 0022-0345
CID: 152684

Halitosis. A common oral problem

Spielman, A I; Bivona, P; Rifkin, B R
Halitosis is caused primarily by bacterial putrefaction and the generation of volatile sulfur compounds. Ninety percent of patients suffering from halitosis have oral causes, such as poor oral hygiene, periodontal disease, tongue coat, food impaction, unclean dentures, faulty restorations, oral carcinomas, and throat infections. The remaining 10 percent of halitosis sufferers have systemic causes that include renal or hepatic failure, carcinomas, diabetes or trimethylaminuria. Modern analytical and microbiological techniques permit diagnosis of bad breath. Management of halitosis involves maintaining proper oral hygiene, and periodontal treatment, including tongue brushing
PMID: 9002736
ISSN: 0028-7571
CID: 152579

Minority Oral Health Research Center. Improving oral health and expanding opportunities

LeGeros, R Z; Margolis, H; Spielman, A; Bivona, P
To address the glaring problems of disparity in oral health and representation in the manpower pool of oral health researchers, the National Institute for Dental Research (NIDR) of the National Institutes of Health established Regional Research Centers for Minority Oral Health. The Minority Oral Health Research Center at New York University College of Dentistry, a collaboration between the college and the Fosyth Dental Center, is one of four centers established by the NIDR in the United States to improve oral health for all Americans and to enhance accessibility of research careers for minority individuals. This article describes the center's progress to date, expected outcomes and its call for partners to improve minority oral health.
PMID: 8973105
ISSN: 0028-7571
CID: 156433

Determination of sleep and wakefulness with the actigraph data analysis software (ADAS)

Jean-Louis, G; von Gizycki, H; Zizi, F; Fookson, J; Spielman, A; Nunes, J; Fullilove, R; Taub, H
Current evidence has shown that, overall, actigraphy is an excellent tool for unobtrusive documentation of sleep/wake activity in normal individuals. However, a number of methodological issues remain to be resolved to warrant its use in clinical research. In this paper, we report the results of a study aimed at the development of a new scoring software that can accurately identify sleep and wakefulness. Using total sleep time as an index of comparison, the software was optimized on a calibration sample and prospectively tested on a validation sample. A strong correlation coefficient (r = 0.93, p < 0.008), with an average discrepancy value of 10 minutes, was observed for the calibration sample. The application of the optimal software to the validation sample revealed an even higher correlation coefficient (r = 0.97, p < 0.0001), with an average discrepancy value of 12 minutes.
PMID: 9122562
ISSN: 0161-8105
CID: 308072

Regulation of extracellular calcium sensing in rat osteoclasts by femtomolar calcitonin concentrations

Zaidi, M; Shankar, V S; Adebanjo, O A; Lai, F A; Pazianas, M; Sunavala, G; Spielman, A I; Rifkin, B R
Certain eukaryotic cells can sense changes in their extracellular Ca2+ concentration through molecular structures termed Ca(2+)-sensing receptors (CaRs). We have shown recently that in the bone-resorbing osteoclast, a unique cell surface-expressed ryanodine receptor (RyR), functions as the CaR. The present study demonstrates that the sensitivity of this receptor is modulated by physiological femtomolar concentrations of the bone-conserving hormone, calcitonin. Calcitonin was found to inhibit cytosolic Ca2+ responses to both Ca2+ and Ni2+. The latter inhibition was mimicked by amylin (10(-12) M), calcitonin gene-related peptide (10(-12) M), cholera toxin (5 micrograms/l) and dibutyryl adenosine 3',5'-cyclic monophosphate (cAMP) (2.5 x 10(-4) or 5 x 10(-4) M) and was reversed by the protein kinase A phosphorylation inhibitor, IP-20. Finally, using a quench flow module, we showed that cellular cAMP levels rise to a peak within 25 ms of calcitonin application; this is consistent with the peptide's rapid effect on CaR activation. We conclude, therefore, that cAMP plays a critical role in the control of CaR function by calcitonin
PMID: 8853426
ISSN: 0002-9513
CID: 153037

A human axillary odorant is carried by apolipoprotein D

Zeng, C; Spielman, A I; Vowels, B R; Leyden, J J; Biemann, K; Preti, G
The characterization of the source of the odor in the human axillary region is not only of commercial interest but is also important biologically because axillary extracts can alter the length and timing of the female menstrual cycle. In males, the most abundant odor component is known to be E-3-methyl-2-hexenoic acid (E-3M2H), which is liberated from nonodorous apocrine secretions by axillary microorganisms. Recently, it was found that in the apocrine gland secretions, 3M2H is carried to the skin surface bound to two proteins, apocrine secretion odor-binding proteins 1 and 2 (ASOB1 and ASOB2) with apparent molecular masses of 45 kDa and 26 kDa, respectively. To better understand the formation of axillary odors and the structural relationship between 3M2H and its carrier protein, the amino acid sequence and glycosylation pattern of ASOB2 were determined by mass spectrometry. The ASOB2 protein was identified as apolipoprotein D (apoD), a known member of the alpha2mu-microglobulin superfamily of carrier proteins also known as lipocalins. The pattern of glycosylation for axillary apoD differs from that reported for plasma apoD, suggesting different sites of expression for the two glycoproteins. In situ hybridization of an oligonucleotide probe against apoD mRNA with axillary tissue demonstrates that the message for synthesis of this protein is specific to the apocrine glands. These results suggest a remarkable similarity between human axillary secretions and nonhuman mammalian odor sources, where lipocalins have been shown to carry the odoriferous signals used in pheromonal communication
PMCID:39076
PMID: 8692868
ISSN: 0027-8424
CID: 153038

A human axillary odorant is carried by apolipoprotein D [Meeting Abstract]

Zeng, CH; Spielmann, AI; Vowels, BR; Leyden, JJ; Biemann, K; Preti, G
ISI:A1996UC78700384
ISSN: 0022-202x
CID: 152692

Rapid kinetics of second messenger production in bitter taste

Spielman, A I; Nagai, H; Sunavala, G; Dasso, M; Breer, H; Boekhoff, I; Huque, T; Whitney, G; Brand, J G
The tasting of bitter compounds may have evolved as a protective mechanism against ingestion of potentially harmful substances. We have identified second messengers involved in bitter taste and show here for the first time that they are rapid and transient. Using a quench-flow system, we have studied bitter taste signal transduction in a pair of mouse strains that differ in their ability to taste the bitter stimulus sucrose octaacetate (SOA); however, both strains taste the bitter agent denatonium. In both strains of mice, denatonium (10 mM) induced a transient and rapid increase in levels of the second messenger inositol 1,4,5-trisphosphate (IP3) with a maximal production near 75-100 ms after stimulation. In contrast, SOA (100 microM) brought about a similar increase in IP3 only in SOA-taster mice. The response to SOA was potentiated in the presence of GTP (1 microM). The GTP-enhanced SOA-response supports a G protein-mediated response for this bitter compound. The rapid kinetics, transient nature, and specificity of the bitter taste stimulus-induced IP3 formation are consistent with the role of IP3 as a second messenger in the chemoelectrical transduction of bitter taste
PMID: 8638676
ISSN: 0002-9513
CID: 153039

Sweat-odorant binding protein identified in human submandibular saliva [Meeting Abstract]

Spielman, AI; Lam, W; Zeng, XN; Preti, G
ISI:A1996TT80100600
ISSN: 0022-0345
CID: 152695